Comparison
46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078 vs 4 Hydroxyphenylacetic Aciduria C1848680
Clinical comparison between 46 XX Disorder OF Sex Development Anorectal Anomalies Syndrome and 4 Hydroxyphenylacetic Aciduria for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078
A rare genetic syndrome affecting an XX individual, causing both differences in sexual development and anal-rectal abnormalities. It is congenital and severe. Surgical correction and long-term specialist care are typically required.
4 Hydroxyphenylacetic Aciduria C1848680
A metabolic disorder where the body cannot properly break down certain amino acids. Typically detected in infancy through screening. Treated with dietary modifications and monitoring.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078
0-0
4 Hydroxyphenylacetic Aciduria C1848680
Variable
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078
severe
4 Hydroxyphenylacetic Aciduria C1848680
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078
Chronic
4 Hydroxyphenylacetic Aciduria C1848680
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078
No
4 Hydroxyphenylacetic Aciduria C1848680
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078
reproductive
4 Hydroxyphenylacetic Aciduria C1848680
metabolic
Same/different system
Category
46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078
rare-disease
4 Hydroxyphenylacetic Aciduria C1848680
metabolic
Different category
Bottom line
46-xx-disorder-of-sex-development-anorectal-anomalies-syndrome-C4518078 and 4-hydroxyphenylacetic-aciduria-C1848680 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078 | 4 Hydroxyphenylacetic Aciduria C1848680 | Discriminating power |
|---|---|---|---|
| Genital or anorectal anatomy | Congenital differences of sex development plus anal-rectal anomalies are defining features. | No established genital or anorectal malformation is described. | High |
| Metabolic presentation | A primary amino-acid metabolic presentation is not established. | Impaired handling of certain amino acids may be detected, often in infancy. | High |
| Age and course | Present from birth and described as severe and chronic. | Onset is variable; typically identified through infancy screening and monitored chronically. | Moderate |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078 when
Newborn with atypical genital anatomy and anorectal anomaly
This combination matches the congenital syndrome description.
High
Need for reconstructive and multidisciplinary congenital care
Surgical correction and long-term specialist care are typically required.
Moderate
46,XX karyotype with developmental differences
The named syndrome specifically concerns an XX individual.
Moderate
Choose 4 Hydroxyphenylacetic Aciduria C1848680 when
Abnormal organic-acid or amino-acid screening result
The condition is a metabolic abnormality, not an anatomic syndrome.
High
Infant needing dietary review after metabolic testing
Management is described as dietary modification and monitoring.
Moderate
No congenital anorectal or sex-development anomaly
Absence of those features makes the anatomic syndrome less fitting.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078 | 4 Hydroxyphenylacetic Aciduria C1848680 | Interpretation |
|---|---|---|---|
| Physical and imaging assessment | May document genital and anorectal anomalies. | No characteristic structural anomaly is established. | Anatomy supports the left condition but does not exclude unrelated metabolic disease. |
| Karyotype or sex-chromosome testing | 46,XX is part of the syndrome name. | No specific karyotype association is established. | Karyotype helps characterize the left condition; it does not diagnose the metabolic condition. |
| Urine organic acids or metabolic panel | No specific metabolite pattern is established. | May show 4-hydroxyphenylacetic acid or related amino-acid abnormalities. | An abnormal result is not by itself a complete diagnosis and needs clinician confirmation. |
Prognosis comparison
46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078
- Outcome
- Chronic congenital condition; exact survival and function are not established.
- Factors
- Anatomy, surgical results, and access to specialist care.
4 Hydroxyphenylacetic Aciduria C1848680
- Outcome
- Often managed with diet and monitoring; long-term outcome is not established.
- Factors
- Biochemical control, adherence, and associated findings.
Time frame: Lifelong follow-up may be needed; precise timelines are unavailable.
Severity differs in source data, but individual prognosis requires clinical assessment.
Complications comparison
| Complication | Presentation |
|---|---|
| Surgical and continence issues | Anorectal anomalies may require correction and ongoing bowel care. Not an established feature. Complication risk depends on anatomy and surgical course. |
| Endocrine or reproductive concerns | Differences of sex development may need specialist follow-up. No established reproductive complication is described. Individual fertility and hormone effects are not established here. |
| Metabolic imbalance | Not described as a primary metabolic disorder. May require dietary adjustment and biochemical monitoring. Exact thresholds, complications, and outcomes are not established. |
Patient education highlights
- HighDifferent conditions
One is a congenital anatomic and developmental syndrome; the other concerns amino-acid metabolism.
- HighSpecialist care
The left condition often needs surgery and long-term specialists; the right needs metabolic monitoring.
- MediumTest meaning
An abnormal metabolite result is not automatically a diagnosis and should be interpreted clinically.